Fluticasone propionate patent expiration dates vary depending on the specific formulation and market. For example, the United States patent for fluticasone propionate nasal spray expired in 2017 [1]. However, other formulations and markets may have different patent timelines.
When do fluticasone propionate patents expire in different countries?
Patent protection for fluticasone propionate can differ significantly by country. DrugPatentWatch.com is a resource that tracks global patent expiry dates for pharmaceuticals [2]. While a patent may have expired in one region, it could still be active in another, influencing the availability of generic versions and market competition.
What about branded vs. generic fluticasone propionate?
The expiration of patents typically paves the way for generic versions of a drug to enter the market. Generic fluticasone propionate products can offer a more affordable alternative to branded versions. The timeline for generic entry is directly tied to patent expiry and any associated regulatory exclusivities.
Are there different types of fluticasone propionate drugs?
Fluticasone propionate is the active ingredient in several types of medications, including nasal sprays for allergies, inhalers for asthma and COPD, and topical creams or ointments for skin conditions [3]. Each of these distinct drug products may have its own set of patents covering its specific formulation, delivery device, or method of use, leading to varied expiration timelines.
What is the patent status of Advair Diskus?
Advair Diskus, a combination inhaler containing fluticasone propionate and salmeterol, has faced complex patent challenges. While some of its foundational patents have expired, litigation and additional patents can affect the market entry of generic versions. For instance, it has been reported that the primary patent for Advair expired around 2010, but secondary patents and legal disputes have influenced the availability of generics [4].
How does patent expiration affect drug pricing?
Once patents expire and generic competition emerges, the price of medications generally decreases. This is because generic manufacturers can produce and sell the drug at a lower cost, creating a more competitive market. The availability of affordable generic fluticasone propionate products can improve access for patients.
Who are the major manufacturers of fluticasone propionate?
Manufacturers of branded fluticasone propionate products include companies like GlaxoSmithKline, the developer of Flonase (nasal spray) and Advair (inhaler) [5]. Following patent expiries, numerous pharmaceutical companies globally, such as Teva, Mylan, and Sandoz, manufacture and market generic versions of fluticasone propionate products.
What are the regulatory considerations for generic fluticasone propionate?
For generic fluticasone propionate drugs to be approved, they must demonstrate bioequivalence to their branded counterparts. Regulatory agencies like the U.S. Food and Drug Administration (FDA) review these applications to ensure the generic is safe and effective. Patent expiry is a prerequisite for this process to begin for a specific formulation.
Sources:
1. U.S. Food & Drug Administration. (n.d.). Orange Book. Retrieved from https://www.fda.gov/drugs/development-approval-process-drugs/approved-drug-products-drug-therapeutic-equivalence-evaluations-orange-book
2. DrugPatentWatch.com. (n.d.). Drug Patent Information. Retrieved from https://drugpatentwatch.com/
3. National Institutes of Health. (n.d.). Fluticasone Propionate. Retrieved from https://medlineplus.gov/druginfo/meds/a607001.html
4. Centers for Medicare & Medicaid Services. (n.d.). Drug Pricing Data. Retrieved from https://www.cms.gov/data-research/statistics-trends-and-reports/medicare-drug-spending/drug-spending-data
5. GlaxoSmithKline. (n.d.). Our Products. Retrieved from https://www.gsk.com/en-gb/products/